Clinical trials
Phase 1 Carcinoma, Transitional Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| Adaptimmune | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Cell Genesys | 1 |
| Genentech, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Institute (NCI) | 1 |
| Shattuck Labs, Inc. | 1 |
| Theralase® Technologies Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 11 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Melanoma | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Carcinoma, Renal Cell | 4 |
| Urinary Bladder Neoplasms | 4 |
| Esophageal Neoplasms | 3 |
| Neoplasms | 3 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.